Cervical cytology screening and evaluation

Obstetrics and Gynecology

Volumn 106, Issue 2, 2005, Pages 391-397

  Noller, Kenneth L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

CANCER SCREENING; COLPOSCOPY; EVALUATION; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SEXUAL BEHAVIOR; TECHNIQUE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 22544488075     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000172427.44160.0e     Document Type: Review

References (32)

1. Noller KL, Bettes B, Zinberg S, Schulkin J. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol 2003;102:259-65.
2. Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol 2000;96:219-23
3. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. (replaces committee opinion 152, March 1995). Obstet Gynecol 2003; 102:417-27.
4. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9
5. US Preventive Services Task Force Report. Screening for cervical cancer. 2003. Available at http://www.ahrq.gov/clinic/uspstf/uspscerv.htm Retrieved June 8, 2005.
6. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10:122-63.
7. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004;364:1678-83.
8. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
9. Noller KL, O'Brien PC, Melton LJ 3rd, Offord JR, Richart RM, Robboy SJ, et al. Coital risk factors for cervical cancer. Sexual activity among white middle class women. Am J Clin Oncol 1987;10:222-6.
10. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
11. Kiviat N. Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol 1996;175:1099-104.
12. Yost NP, Santoso JT, McIntire DD, IIiya FA. Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions. Obstet Gynecol. 1999;93:39-62.
13. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93.
14. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
15. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. [published erratum appears in Gynecol Oncol 2002;84:355]. Gynecol Oncol 2001;83:439-44.
16. Sawaya GF, Grady D, Kerlikowske K, Valleur JL, Barnabei VM, Bass K, et al. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med 2000;133:942-50.
17. Cooper SP, Hardy RJ, Labarthe DR, Hawkins CM, Smith EO, Blaufox MD, et al. The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program. Am J Epidemiol 1988;127:387-403.
18. Chockalingam A, Campbell N, Ruddy T, Taylor G, Stewart P; Expert Working Group. Canadian national high blood pressure prevention and control strategy. Can J Cardiol 2000;16: 1087-93.
19. Grimes DA, Atkins D. The U.S. Preventive Services Task Force: putting evidence-based medicine to work. Clin Obstet Gynecol 1998;41:332-42.
20. Whitlock EP, Orleans CT, Pender N, Allan J. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med 2002; May;22:267-84.
21. Pearce KF, Haefner HK, Sarwar SF, Nolan TE Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease. N Engl J Med 1996;335: 1559-62.
22. Federal Drug Administration. FDA approves expanded use of HPV test. 2003. Available at http://www.fda.gov/bbs/topics/NEWS/2003/NEW00890.html Retrieved June 8, 2005.
23. Wright TC Jr., Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, Hatch K, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103:304-9.
24. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002;287:2372-81.
25. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994;271:1866-9.
26. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ; American Society for Colposcopy and Cervical Pathology. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.
27. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91: 973-6.
28. Solomon D, Schiffman M, Tarone R; ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93: 293-9.
29. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-90.
30. Noller KL, Bibace R. The centrality of the clinician in the evaluation of patients with abnormal cervical cytologic studies. Am J Obstet Gynecol 2002;187:1533-5.
31. [No authors listed] Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000;92:397-402.
32. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65:314-8.